Lv11
30 积分 2022-08-03 加入
Teclistamab-Induced Remission in Refractory Systemic Lupus Erythematosus
2小时前
待确认
Achievable but elusive: LLDAS and DORIS remission in clinical trials of belimumab
2小时前
已完结
P3.13D.09 Prevalence and Prognostic Impact of SEZ6 Expression in a Real-World Cohort of Patients with Small-Cell Lung Cancer
26天前
已关闭
Newly approved anti-CD19 monoclonal antibodies for the treatment of relapsed or refractory diffuse large B-cell lymphoma
1个月前
已完结
Bispecific Antibodies for Non-Hodgkin Lymphoma Treatment
2个月前
已完结
Toxicities and side effects associated with intravenous infusions of murine monoclonal antibodies
2个月前
已关闭
A Trispecific Antibody Induces Potent Tumor-Directed T-Cell Activation and Antitumor Activity by CD3/CD28 Co-Engagement
2个月前
已完结
Epcoritamab monotherapy in patients with relapsed or refractory follicular lymphoma (EPCORE NHL-1): a phase 2 cohort of a single-arm, multicentre study
3个月前
已完结
Epcoritamab monotherapy in patients with relapsed or refractory follicular lymphoma (EPCORE NHL-1): a phase 2 cohort of a single-arm, multicentre study
3个月前
已完结
Assessment of bone marrow involvement in non‐Hodgkin’s lymphomas: comparison between histology and flow cytometry
4个月前
已完结
皖公网安备34019202002308
